title: Stevens-Johnson syndrome associated with methotrexate treatment for non-Hodgkin's lymphoma.
authors.affiliation: Department of Haematology, Royal Infirmary of Edinburgh.
authors.forename: R J
authors.initials: RJ
authors.lastname: Cuthbert
authors.forename: J I
authors.initials: JI
authors.lastname: Craig
authors.forename: C A
authors.initials: CA
authors.lastname: Ludlam
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D011239:Prednisolone / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D012074:Remission Induction; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone; D002955:Leucovorin; D011241:Prednisone; D008727:Methotrexate